Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAIV-T in Healthy Children Aged 6 to Less Than 36 Months
NCT00192322Phase 2Completed
- Sponsor
- MedImmune
- Start
- Sep 2001
- Primary completion
- Dec 2001
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of live attenuated influenza vaccine in influenza (4 arms), sponsored by MedImmune. Primary endpoint: Measurement of influenza-specific immune response following receipt of CAIV-T at Day 27. Started Sep 2001; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00192322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192322.